Accustem SciencesACUT +21.61%27 FCF Yield % is -30.73 as of Jul. 10, 2026. GuruFocus rates ACUT with a GF Score™ of 27/100. The stock has 1 warning sign investors should review. Among 1,408 Biotechnology companies, Accustem Sciences ranks worse than 79.69% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Accustem Sciences FCF Yield % Related Terms
Accustem Sciences FCF Yield % Historical Data
* Premium members only.
The historical data trend for Accustem Sciences's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Accustem Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accustem Sciences FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Accustem Sciences's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Accustem Sciences's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accustem Sciences (ACUT) has a FCF Yield % of -30.73 as of Jul. 10, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Accustem Sciences and its competitors. According to the industry distribution chart, Accustem Sciences ranks #1122 out of 1408 companies in the Biotechnology industry, placing it in the top 79.7%.
Is Accustem Sciences' FCF Yield % too high?
Accustem Sciences' current FCF Yield % is -30.73. Based on the distribution chart, Accustem Sciences ranks #1122 out of 1408 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Accustem Sciences has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Accustem Sciences' FCF Yield % compare to DCOY and BIXT?
According to the Biotechnology industry distribution chart, Accustem Sciences ranks #1122 out of 1408 companies for FCF Yield %. This places Accustem Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Accustem Sciences and its competitors. Accustem Sciences's current FCF Yield % is -30.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accustem Sciences stock overvalued right now?
Accustem Sciences (ACUT) has a current FCF Yield % of -30.73. The current FCF Yield % is -30.73. Accustem Sciences' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Accustem Sciences (ACUT), the current FCF Yield % is -30.73 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accustem Sciences Inc is a clinical stage diagnostics company dedicated to improving quality of life and outcomes for the millions of people who are diagnosed with cancer each year. The company's product, StemPrintER, is a genomic platform for predicting distant recurrence risk in luminal, ER+/HER2-negative breast cancer patients. Additionally, It offers ancillary commodity testing to provide further insights. Validated in various retrospective cohorts, StemPrintER shows promise for oncology clinics. Revenue is generated through product commercialization and testing services.
27GF Score
Get the complete analysis for ACUT
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACUT has been successfully added to your 
